SANA in the 13F filings
Sana Biotechnology Inc · CUSIP 799566104
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 8 May 2026
- Managers listing it
- 23
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 1 listed it in both
- Shares listed
- 54,994,926
- combined, among listed positions
- Reported value
- $159m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 9 buyers (opened or added shares) and 12 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -505,123.
Managers listing SANA in Q1 2026
23 of 23 holders
Largest increases and reductions, by shares
Increases
- Millennium Management LLCexisting position · 1,591,030 shares now+967,788
- Marshall Wace LLPexisting position · 664,457 shares now+575,669
- Citadel Advisors LLCexisting position · 569,090 shares now+555,549
- Tudor Investment Corpnew position · 133,183 shares now+133,183
- ExodusPoint Capital Management LPnew position · 61,659 shares now+61,659
Reductions
- Balyasny Asset Management LLCexisting position · 1,033,804 shares now-645,326
- T. Rowe Price Associates Incexisting position · 207,492 shares now-558,995
- Jane Street Group LLCexisting position · 132,715 shares now-536,169
- Two Sigma Investments LPexisting position · 1,198,579 shares now-381,126
- Renaissance Technologies LLCexisting position · 1,451,200 shares now-239,916
New positions and exits
New (3)
Exited (2)
- Schonfeld Strategic Advisors LLCwas $227k
- Quantbot Technologies LPwas $5k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2021 | 4 | $398m | n.a. | n.a. |
| Q2 2021 | 3 | $259m | n.a. | n.a. |
| Q3 2021 | 4 | $297m | n.a. | n.a. |
| Q4 2021 | 4 | $206m | n.a. | n.a. |
| Q1 2022 | 3 | $106m | n.a. | n.a. |
| Q2 2022 | 3 | $80m | n.a. | n.a. |
| Q3 2022 | 3 | $74m | n.a. | n.a. |
| Q4 2022 | 3 | $46m | n.a. | n.a. |
| Q1 2023 | 3 | $38m | n.a. | n.a. |
| Q2 2023 | 3 | $76m | n.a. | n.a. |
| Q3 2023 | 3 | $47m | n.a. | n.a. |
| Q4 2023 | 3 | $50m | 1 | 1 |
| Q1 2024 | 4 | $171m | 4 | 0 |
| Q2 2024 | 3 | $91m | 0 | 2 |
| Q3 2024 | 3 | $68m | 1 | 1 |
| Q4 2024 | 2 | $26m | 0 | 1 |
| Q1 2025 | 2 | $26m | 0 | 1 |
| Q2 2025 | 1 | $27m | 0 | 2 |
| Q3 2025 | 1 | $41m | 1 | 0 |
| Q4 2025 | 1 | $27m | 13 | 10 |
| Q1 2026 | 1 | $19m | 9 | 12 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
SANA and GILD →SANA and AMGN →SANA and ARGX →Choose a stock to compare with SANA →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own SANA, latest filings →Back to the 13F Explorer →